Redox biology and the interface between bioenergetics, autophagy and circadian control of metabolism

Free Radical Biology and Medicine

Volumn 100, Issue , 2016, Pages 94-107

  Wende, Adam R ^a,c   Young, Martin E ^b,c   Chatham, John ^a,c   Zhang, Jianhua ^a,c   Rajasekaran, Namakkal S ^a,c   Darley Usmar, Victor M ^a,c  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Chronobiology; Keap1; Metabolic shift; Nrf2; Oxidative stress; Reserve capacity

Indexed keywords

KELCH LIKE ECH ASSOCIATED PROTEIN 1; N ACETYLGLUCOSAMINE; TRANSCRIPTION FACTOR NRF2;

ARTICLE; AUTOPHAGY; BIOENERGY; CARDIOVASCULAR FUNCTION; CELLULAR STRESS RESPONSE; CIRCADIAN RHYTHM; EPIGENETICS; GLUCOSE HOMEOSTASIS; HEALTH STATUS; HORMONE RELEASE; HUMAN; LIPID HOMEOSTASIS; METABOLIC REGULATION; MITOCHONDRION; MOLECULAR BIOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN MODIFICATION; PROTEIN PROCESSING; REDOX BIOLOGY; SIGNAL TRANSDUCTION; ANIMAL; ENERGY METABOLISM; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

ACETYLGLUCOSAMINE; ANIMALS; AUTOPHAGY; CIRCADIAN CLOCKS; ENERGY METABOLISM; HUMANS; KELCH-LIKE ECH-ASSOCIATED PROTEIN 1; MITOCHONDRIA; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION;

EID: 84971622073     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2016.05.022     Document Type: Review

References (197)

1. [1] Boveris, A., Chance, B., The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem. J. 134 (1973), 707–716.
2. [2] Murphy, M.P., How mitochondria produce reactive oxygen species. Biochem. J. 417 (2009), 1–13.
3. [3] Chance, B., Sies, H., Boveris, A., Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59 (1979), 527–605.
4. [4] Boveris, A., Oshino, N., Chance, B., The cellular production of hydrogen peroxide. Biochem. J. 128 (1972), 617–630.
5. [5] Al Ghouleh, I., Khoo, N.K., Knaus, U.G., Griendling, K.K., Touyz, R.M., Thannickal, V.J., Barchowsky, A., Nauseef, W.M., Kelley, E.E., Bauer, P.M., Darley-Usmar, V., Shiva, S., Cifuentes-Pagano, E., Freeman, B.A., Gladwin, M.T., Pagano, P.J., Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling. Free Radic. Biol. Med. 51 (2011), 1271–1288.
6. [6] Hill, B.G., Benavides, G.A., Lancaster, J.R. Jr, Ballinger, S., Dell'Italia, L., Jianhua, Z., Darley-Usmar, V.M., Integration of cellular bioenergetics with mitochondrial quality control and autophagy. Biol. Chem. 393 (2012), 1485–1512.
7. [7] Chacko, B.K., Kramer, P.A., Ravi, S., Johnson, M.S., Hardy, R.W., Ballinger, S.W., Darley-Usmar, V.M., Methods for defining distinct bioenergetic profiles in platelets, lymphocytes, monocytes, and neutrophils, and the oxidative burst from human blood. Lab. Investig. J. Tech. Methods Pathol. 93 (2013), 690–700.
8. [8] Quinlan, C.L., Perevoshchikova, I.V., Hey-Mogensen, M., Orr, A.L., Brand, M.D., Sites of reactive oxygen species generation by mitochondria oxidizing different substrates. Redox Biol. 1 (2013), 304–312.
9. [9] Ballinger, S.W., Mitochondrial dysfunction in cardiovascular disease. Free Radic. Biol. Med. 38 (2005), 1278–1295.
10. [10] Levonen, A.L., Patel, R.P., Brookes, P., Go, Y.M., Jo, H., Parthasarathy, S., Anderson, P.G., Darley-Usmar, V.M., Mechanisms of cell signaling by nitric oxide and peroxynitrite: from mitochondria to MAP kinases. Antioxid. Redox Signal. 3 (2001), 215–229.
11. [11] Brookes, P., Darley-Usmar, V.M., Hypothesis: the mitochondrial NO(*) signaling pathway, and the transduction of nitrosative to oxidative cell signals: an alternative function for cytochrome C oxidase. Free Radic. Biol. Med. 32 (2002), 370–374.
12. [12] Dodson, M., Darley-Usmar, V., Zhang, J., Cellular metabolic and autophagic pathways: traffic control by redox signaling. Free Radic. Biol. Med. 63 (2013), 207–221.
13. [13] Butow, R.A., Avadhani, N.G., Mitochondrial signaling: the retrograde response. Mol. Cell 14 (2004), 1–15.
14. [14] Cadenas, E., Mitochondrial free radical production and cell signaling. Mol. Asp. Med. 25 (2004), 17–26.
15. [15] Erusalimsky, J.D., Moncada, S., Nitric oxide and mitochondrial signaling: from physiology to pathophysiology. Arterioscler. Thromb. Vascul. Biol. 27 (2007), 2524–2531.
16. [16] Cooper, C.E., Giulivi, C., Nitric oxide regulation of mitochondrial oxygen consumption II: molecular mechanism and tissue physiology. Am. J. Physiol. Cell Physiol. 292 (2007), C1993–2003.
17. [17] Obre, E., Rossignol, R., Emerging concepts in bioenergetics and cancer research: metabolic flexibility, coupling, symbiosis, switch, oxidative tumors, metabolic remodeling, signaling and bioenergetic therapy. Int. J.Biochem. Cell Biol. 59 (2015), 167–181.
18. [18] Willems, P.H., Rossignol, R., Dieteren, C.E., Murphy, M.P., Koopman, W.J., Redox homeostasis and mitochondrial dynamics. Cell Metab. 22 (2015), 207–218.
19. [19] Rahman, S., Emerging aspects of treatment in mitochondrial disorders. J. Inherit. Metab. Dis. 38 (2015), 641–653.
20. [20] Narendra, D.P., Youle, R.J., Neurodegeneration: trouble in the cell's powerhouse. Nature 483 (2012), 418–419.
21. [21] Santos, R.X., Correia, S.C., Carvalho, C., Cardoso, S., Santos, M.S., Moreira, P.I., Mitophagy in neurodegeneration: an opportunity for therapy?. Curr. Drug Targets 12 (2011), 790–799.
22. [22] Wallace, D.C., Fan, W., Procaccio, V., Mitochondrial energetics and therapeutics. Ann. Rev. Pathol. 5 (2010), 297–348.
23. [23] Krzywanski, D.M., Moellering, D.R., Fetterman, J.L., Dunham-Snary, K.J., Sammy, M.J., Ballinger, S.W., The mitochondrial paradigm for cardiovascular disease susceptibility and cellular function: a complementary concept to Mendelian genetics. Lab. Investig. J. Tech. Methods Pathol. 91 (2011), 1122–1135.
24. [24] Harrison, C.M., Pompilius, M., Pinkerton, K.E., Ballinger, S.W., Mitochondrial oxidative stress significantly influences atherogenic risk and cytokine-induced oxidant production. Environ. Health Perspect. 119 (2011), 676–681.
25. [25] Gutierrez, J., Ballinger, S.W., Darley-Usmar, V.M., Landar, A., Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. Circ. Res. 99 (2006), 924–932.
26. [26] Mitchell, T., Johnson, M.S., Ouyang, X., Chacko, B.K., Mitra, K., Lei, X., Gai, Y., Moore, D.R., Barnes, S., Zhang, J., Koizumi, A., Ramanadham, S., Darley-Usmar, V.M., Dysfunctional mitochondrial bioenergetics and oxidative stress in Akita(+/Ins2)-derived beta-cells. Am. J. Physiol. Endocrinol. Metab. 305 (2013), E585–599.
27. [27] Horton, K.L., Stewart, K.M., Fonseca, S.B., Guo, Q., Kelley, S.O., Mitochondria-penetrating peptides. Chem. Biol. 15 (2008), 375–382.
28. [28] Rehman, H., Ramshesh, V.K., Theruvath, T.P., Kim, I., Currin, R.T., Giri, S., Lemasters, J.J., Zhong, Z., NIM811 (N-methyl-4-isoleucine cyclosporine), a mitochondrial permeability transition inhibitor, attenuates cholestatic liver injury but not fibrosis in mice. J. Pharmacol. Exp. Ther. 327 (2008), 699–706.
29. [29] Burchell, V.S., Gandhi, S., Deas, E., Wood, N.W., Abramov, A.Y., Plun-Favreau, H., Targeting mitochondrial dysfunction in neurodegenerative disease: Part II. Expert Opin. Ther. Targets 14 (2010), 497–511.
30. [30] Carreira, R.S., Lee, P., Gottlieb, R.A., Mitochondrial therapeutics for cardioprotection. Curr. Pharm. Des. 17 (2011), 2017–2035.
31. [31] Murphy, M.P., Targeting lipophilic cations to mitochondria. Biochim. Biophys. Acta 1777 (2008), 1028–1031.
32. [32] Whitaker-Menezes, D., Martinez-Outschoorn, U.E., Flomenberg, N., Birbe, R.C., Witkiewicz, A.K., Howell, A., Pavlides, S., Tsirigos, A., Ertel, A., Pestell, R.G., Broda, P., Minetti, C., Lisanti, M.P., Sotgia, F., Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue. Cell Cycle 10 (2011), 4047–4064.
33. [33] Gohil, V.M., Sheth, S.A., Nilsson, R., Wojtovich, A.P., Lee, J.H., Perocchi, F., Chen, W., Clish, C.B., Ayata, C., Brookes, P.S., Mootha, V.K., Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis. Nat. Biotechnol. 28 (2010), 249–255.
34. [34] Brookes, P.S., Levonen, A.L., Shiva, S., Sarti, P., Darley-Usmar, V.M., Mitochondria: regulators of signal transduction by reactive oxygen and nitrogen species. Free Radic. Biol. Med. 33 (2002), 755–764.
35. [35] Higdon, A., Diers, A.R., Oh, J.Y., Landar, A., Darley-Usmar, V.M., Cell signalling by reactive lipid species: new concepts and molecular mechanisms. Biochem. J. 442 (2012), 453–464.
36. [36] Fetterman, J.L., Zelickson, B.R., Johnson, L.W., Moellering, D.R., Westbrook, D.G., Pompilius, M., Sammy, M.J., Johnson, M., Dunham-Snary, K.J., Cao, X., Bradley, W.E., Zhang, J., Wei, C.C., Chacko, B., Schurr, T.G., Kesterson, R.A., Dell'italia, L.J., Darley-Usmar, V.M., Welch, D.R., Ballinger, S.W., Mitochondrial genetic background modulates bioenergetics and susceptibility to acute cardiac volume overload. Biochem. J. 455 (2013), 157–167.
37. [37] Lemasters, J.J., Variants of mitochondrial autophagy: types 1 and 2 mitophagy and micromitophagy (Type 3). Redox Biol. 2 (2014), 749–754.
38. [38] Zhang, J., Teaching the basics of autophagy and mitophagy to redox biologists—mechanisms and experimental approaches. Redox Biol. 4 (2015), 242–259.
39. [39] Lee, J., Giordano, S., Zhang, J., Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem. J. 441 (2012), 523–540.
40. [40] Giordano, S., Darley-Usmar, V., Zhang, J., Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease. Redox Biol. 2 (2014), 82–90.
41. [41] Gamble, K.L., Berry, R., Frank, S.J., Young, M.E., Circadian clock control of endocrine factors. Nat. Rev. Endocrinol. 10 (2014), 466–475.
42. [42] Bass, J., Takahashi, J.S., Circadian integration of metabolism and energetics. Science 330 (2010), 1349–1354.
43. [43] Takahashi, J.S., Hong, H.K., Ko, C.H., McDearmon, E.L., The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat. Rev. Genet. 9 (2008), 764–775.
44. [44] Edgar, R.S., Green, E.W., Zhao, Y., van Ooijen, G., Olmedo, M., Qin, X., Xu, Y., Pan, M., Valekunja, U.K., Feeney, K.A., Maywood, E.S., Hastings, M.H., Baliga, N.S., Merrow, M., Millar, A.J., Johnson, C.H., Kyriacou, C.P., O'Neill, J.S., Reddy, A.B., Peroxiredoxins are conserved markers of circadian rhythms. Nature 485 (2012), 459–464.
45. [45] Stangherlin, A., Reddy, A.B., Regulation of circadian clocks by redox homeostasis. J. Biol. Chem. 288 (2013), 26505–26511.
46. [46] Pearce, E.L., Poffenberger, M.C., Chang, C.H., Jones, R.G., Fueling immunity: insights into metabolism and lymphocyte function. Science, 342, 2013, 1242454.
47. [47] Pearce, E.L., Pearce, E.J., Metabolic pathways in immune cell activation and quiescence. Immunity 38 (2013), 633–643.
48. [48] Tavakoli, S., Zamora, D., Ullevig, S., Asmis, R., Bioenergetic profiles diverge during macrophage polarization: implications for the interpretation of 18F-FDG PET imaging of atherosclerosis. J. Nucl. Med. 54 (2013), 1661–1667.
49. [49] Ravi, S., Mitchell, T., Kramer, P.A., Chacko, B., Darley-Usmar, V.M., Mitochondria in monocytes and macrophages-implications for translational and basic research. Int. J.Biochem. Cell Biol. 53C (2014), 202–207.
50. [50] Bird, A., Perceptions of epigenetics. Nature 447 (2007), 396–398.
51. [51] Salminen, A., Haapasalo, A., Kauppinen, A., Kaarniranta, K., Soininen, H., Hiltunen, M., Impaired mitochondrial energy metabolism in Alzheimer's disease: impact on pathogenesis via disturbed epigenetic regulation of chromatin landscape. Progr. Neurobiol. 131 (2015), 1–20.
52. [52] Kumar, R., Li, D.Q., Muller, S., Knapp, S., Epigenomic regulation of oncogenesis by chromatin remodeling. Oncogene, 2016.
53. [53] Wende, A.R., Post-translational modifications of the cardiac proteome in diabetes and heart failure. Proteom. Clin. Appl. 10 (2016), 25–38.
54. [54] Schones, D.E., Leung, A., Natarajan, R., Chromatin modifications associated with diabetes and obesity. Arterioscler. Thromb. Vasc. Biol. 35 (2015), 1557–1561.
55. [55] Gut, P., Verdin, E., The nexus of chromatin regulation and intermediary metabolism. Nature 502 (2013), 489–498.
56. [56] Shaughnessy, D.T., McAllister, K., Worth, L., Haugen, A.C., Meyer, J.N., Domann, F.E., Van Houten, B., Mostoslavsky, R., Bultman, S.J., Baccarelli, A.A., Begley, T.J., Sobol, R.W., Hirschey, M.D., Ideker, T., Santos, J.H., Copeland, W.C., Tice, R.R., Balshaw, D.M., Tyson, F.L., Mitochondria, energetics, epigenetics, and cellular responses to stress. Environ. Health Perspect. 122 (2014), 1271–1278.
57. [57] Daiber, A., Münzel, T., Organic nitrate therapy, nitrate tolerance, and nitrate-induced endothelial dysfunction: emphasis on redox biology and oxidative stress. Antioxid. Redox Signal. 23 (2015), 899–942.
58. [58] Vasudevan, D., Hickok, J.R., Bovee, R.C., Pham, V., Mantell, L.L., Bahroos, N., Kanabar, P., Cao, X.-J., Maienschein-Cline, M., Garcia, B.A., Thomas, D.D., Nitric oxide regulates gene expression in cancers by controlling histone posttranslational modifications. Cancer Res. 75 (2015), 5299–5308.
59. [59] Hickok, J.R., Vasudevan, D., Antholine, W.E., Thomas, D.D., Nitric oxide modifies global histone methylation by inhibiting Jumonji C domain-containing demethylases. J. Biol. Chem. 288 (2013), 16004–16015.
60. [60] Olivier-Van Stichelen, S., Hanover, J.A., You are what you eat: O-linked N-acetylglucosamine in disease, development and epigenetics. Curr. Opin. Clin. Nutr. Metab. Care 18 (2015), 339–345.
61. [61] Hardivillé, S., Hart, G.W., Nutrient regulation of signaling, transcription, and cell physiology by O-GlcNAcylation. Cell Metab. 20 (2014), 208–213.
62. [62] Darley-Usmar, V.M., Ball, L.E., Chatham, J.C., Protein O-linked beta-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function. J. Mol. Cell. Cardiol. 52 (2012), 538–549.
63. [63] Cai, D., Yin, S., Yang, J., Jiang, Q., Cao, W., Histone deacetylase inhibition activates Nrf2 and protects against osteoarthritis. Arthr. Res. Ther. 17 (2015), 1–11.
64. [64] Rajendran, P., Dashwood, W.-M., Li, L., Kang, Y., Kim, E., Johnson, G., Fischer, K.A., Löhr, C.V., Williams, D.E., Ho, E., Yamamoto, M., Lieberman, D.A., Dashwood, R.H., Nrf2 status affects tumor growth, HDAC3 gene promoter associations, and the response to sulforaphane in the colon. Clin. Epigenet. 7 (2015), 1–12.
65. [65] Mishra, M., Zhong, Q., Kowluru, R.A., Epigenetic modifications of Nrf2-mediated glutamate–cysteine ligase: implications for the development of diabetic retinopathy and the metabolic memory phenomenon associated with its continued progression. Free Radic. Biol. Med. 75 (2014), 129–139.
66. [66] Boyanapalli, S.S., Tony Kong, A.N., “Curcumin, the King of Spices”: epigenetic regulatory mechanisms in the prevention of cancer, neurological, and inflammatory diseases. Curr. Pharmacol. Rep. 1 (2015), 129–139.
67. [67] Gu, X., Sun, J., Li, S., Wu, X., Li, L., Oxidative stress induces DNA demethylation and histone acetylation in SH-SY5Y cells: potential epigenetic mechanisms in gene transcription in Aβ production. Neurobiol. Aging 34 (2013), 1069–1079.
68. [68] Park, G., Tan, J., Garcia, G., Kang, Y., Salvesen, G., Zhang, Z., Regulation of histone acetylation by autophagy in Parkinson disease. J. Biol. Chem. 291 (2016), 3531–3540.
69. [69] Hart, G.W., Slawson, C., Ramirez-Correa, G., Lagerlof, O., Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu. Rev. Biochem. 80 (2011), 825–858.
70. [70] Bond, M.R., Hanover, J.A., A little sugar goes a long way: the cell biology of O-GlcNAc. J. Cell. Biol. 208 (2015), 869–880.
71. [71] Chen, Q., Chen, Y., Bian, C., Fujiki, R., Yu, X., TET2 promotes histone O-GlcNAcylation during gene transcription. Nature 493 (2013), 561–564.
72. [72] Shi, F.-T., Kim, H., Lu, W., He, Q., Liu, D., Goodell, M.A., Wan, M., Songyang, Z., Ten-eleven translocation 1 (Tet1) is regulated by O-Linked N-acetylglucosamine transferase (Ogt) for target gene repression in mouse embryonic stem cells. J. Biol. Chem. 288 (2013), 20776–20784.
73. [73] Deplus, R., Delatte, B., Schwinn, M.K., Defrance, M., Mendez, J., Murphy, N., Dawson, M.A., Volkmar, M., Putmans, P., Calonne, E., Shih, A.H., Levine, R.L., Bernard, O., Mercher, T., Solary, E., Urh, M., Daniels, D.L., Fuks, F., TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS. EMBO J. 32 (2013), 645–655.
74. [74] Minor, E.A., Court, B.L., Young, J.I., Wang, G., Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine. J. Biol. Chem. 288 (2013), 13669–13674.
75. [75] Du, X.L., Edelstein, D., Rossetti, L., Fantus, I.G., Goldberg, H., Ziyadeh, F., Wu, J., Brownlee, M., Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc. Natl. Acad. Sci. USA 97 (2000), 12222–12226.
76. [76] Du, X.L., Edelstein, D., Dimmeler, S., Ju, Q., Sui, C., Brownlee, M., Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J. Clin. Invest. 108 (2001), 1341–1348.
77. [77] Hu, Y., Suarez, J., Fricovsky, E., Wang, H., Scott, B.T., Trauger, S.A., Han, W., Oyeleye, M.O., Dillmann, W.H., Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose. J. Biol. Chem. 284 (2009), 547–555.
78. [78] Gawlowski, T., Suarez, J., Scott, B., Torres-Gonzalez, M., Wang, H., Schwappacher, R., Han, X., Yates, J., Hoshijima, M., Dillmann, W.H., Modulation of dynamin-related protein 1 (DRP1) function by increased O-linked-beta-N-acetylglucosamine modification (O-GlcNAc) in cardiac myocytes. J. Biol. Chem., 2012.
79. [79] Palaniappan, K.K., Hangauer, M.J., Smith, T.J., Smart, B.P., Pitcher, A.A., Cheng, E.H., Bertozzi, C.R., Boyce, M., A chemical glycoproteomics platform reveals O-GlcNAcylation of mitochondrial voltage-dependent anion channel 2. Cell Rep. 5 (2013), 546–552.
80. [80] Dassanayaka, S., Readnower, R.D., Salabei, J.K., Long, B.W., Aird, A.L., Zheng, Y.T., Muthusamy, S., Facundo, H.T., Hill, B.G., Jones, S.P., High glucose induces mitochondrial dysfunction independently of protein O-GlcNAcylation. Biochem. J. 467 (2015), 115–126.
81. [81] Banerjee, P.S., Ma, J., Hart, G.W., Diabetes-associated dysregulation of O-GlcNAcylation in rat cardiac mitochondria. Proc. Natl. Acad. Sci. USA 112 (2015), 6050–6055.
82. [82] Zachara, N.E., O'Donnell, N., Cheung, W.D., Mercer, J.J., Marth, J.D., Hart, G.W., Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J. Biol. Chem. 279 (2004), 30133–30142.
83. [83] Champattanachai, V., Marchase, R.B., Chatham, J.C., Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2. Am. J. Physiol. Cell Physiol. 294 (2008), C1509–1520.
84. [84] Ngoh, G.A., Watson, L.J., Facundo, H.T., Jones, S.P., Augmented O-GlcNAc signaling attenuates oxidative stress and calcium overload in cardiomyocytes. Amino Acids 40 (2011), 895–911.
85. [85] Ngoh, G.A., Watson, L.J., Facundo, H.T., Dillmann, W., Jones, S.P., Non-canonical glycosyltransferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transition. J. Mol. Cell. Cardiol. 45 (2008), 313–325.
86. [86] Ngoh, G.A., Facundo, H.T., Hamid, T., Dillmann, W., Zachara, N.E., Jones, S.P., Unique hexosaminidase reduces metabolic survival signal and sensitizes cardiac myocytes to hypoxia/reoxygenation injury. Circ. Res. 104 (2009), 41–49.
87. [87] Marsh, S.A., Powell, P.C., Dell'italia, L.J., Chatham, J.C., Cardiac O-GlcNAcylation blunts autophagic signaling in the diabetic heart. Life Sci. 92 (2013), 648–656.
88. [88] Zafir, A., Readnower, R., Long, B.W., McCracken, J., Aird, A., Alvarez, A., Cummins, T.D., Li, Q., Hill, B.G., Bhatnagar, A., Prabhu, S.D., Bolli, R., Jones, S.P., Protein O-GlcNAcylation is a novel cytoprotective signal in cardiac stem cells. Stem Cells 31 (2013), 765–775.
89. [89] Love, D.C., Kochan, J., Cathey, R.L., Shin, S.H., Hanover, J.A., Mitochondrial and nucleocytoplasmic targeting of O-linked GlcNAc transferase. J. Cell Sci. 116 (2003), 647–654.
90. [90] Ma, J., Liu, T., Wei, A.C., Banerjee, P., O'Rourke, B., Hart, G.W., O-GlcNAcomic profiling identifies widespread O-linked beta-N-acetylglucosamine modification (O-GlcNAcylation) in oxidative phosphorylation system regulating cardiac mitochondrial function. J. Biol. Chem. 290 (2015), 29141–29153.
91. [91] Dranka, B.P., Benavides, G.A., Diers, A.R., Giordano, S., Zelickson, B.R., Reily, C., Zou, L.Y., Chatham, J.C., Hill, B.G., Zhang, J.H., Landar, A., Darley-Usmar, V.M., Assessing bioenergetic function in response to oxidative stress by metabolic profiling. Free Radic. Biol. Med. 51 (2011), 1621–1635.
92. [92] Rossignol, R., Faustin, B., Rocher, C., Malgat, M., Mazat, J.P., Letellier, T., Mitochondrial threshold effects. Biochem. J. 370 (2003), 751–762.
93. [93] Dranka, B.P., Benavides, G.A., Diers, A.R., Giordano, S., Zelickson, B.R., Reily, C., Zou, L., Chatham, J.C., Hill, B.G., Zhang, J., Landar, A., Darley-Usmar, V.M., Assessing bioenergetic function in response to oxidative stress by metabolic profiling. Free Radic. Biol. Med. 51 (2011), 1621–1635.
94. [94] Brand, M.D., Nicholls, D.G., Assessing mitochondrial dysfunction in cells. Biochem. J. 435 (2011), 297–312.
95. [95] Turrens, J.F., Mitochondrial formation of reactive oxygen species. J. Physiol. 552 (2003), 335–344.
96. [96] Higdon, A.N., Benavides, G.A., Chacko, B.K., Ouyang, X., Johnson, M.S., Landar, A., Zhang, J., Darley-Usmar, V.M., Hemin causes mitochondrial dysfunction in endothelial cells through promoting lipid peroxidation: the protective role of autophagy. Am. J. Physiol. Heart Circul. Physiol. 302 (2012), H1394–1409.
97. [97] Sansbury, B.E., Jones, S.P., Riggs, D.W., Darley-Usmar, V.M., Hill, B.G., Bioenergetic function in cardiovascular cells: the importance of the reserve capacity and its biological regulation. Chem.-Biol. Interact. 191 (2011), 288–295.
98. [98] Diers, A.R., Broniowska, K.A., Chang, C.F., Hogg, N., Pyruvate fuels mitochondrial respiration and proliferation of breast cancer cells: effect of monocarboxylate transporter inhibition. Biochem. J. 444 (2012), 561–571.
99. [99] Chacko, B.K., Kramer, P.A., Ravi, S., Benavides, G.A., Mitchell, T., Dranka, B.P., Ferrick, D., Singal, A.K., Ballinger, S.W., Bailey, S.M., Hardy, R.W., Zhang, J., Zhi, D., Darley-Usmar, V.M., The bioenergetic health index: a new concept in mitochondrial translational research. Clin. Sci. 127 (2014), 367–373.
100. [100] Kramer, P.A., Chacko, B.K., George, D.J., Zhi, D., Wei, C.C., Dell'Italia, L.J., Melby, S.J., George, J.F., Darley-Usmar, V., Decreased bioenergetic health index in monocytes isolated from the pericardial fluid and blood of post-operative cardiac surgery patients. Biosci. Rep., 2015.
101. [101] Czajka, A., Ajaz, S., Gnudi, L., Parsade, C.K., Jones, P., Reid, F., Malik, A.N., Altered mitochondrial function, mitochondrial DNA and reduced metabolic flexibility in patients with diabetic nephropathy. EBioMedicine, 2015.
102. [102] Cardenes, N., Corey, C., Geary, L., Jain, S., Zharikov, S., Barge, S., Novelli, E.M., Shiva, S., Platelet bioenergetic screen in sickle cell patients reveals mitochondrial complex V inhibition, which contributes to platelet activation. Blood 123 (2014), 2864–2872.
103. [103] Zharikov, S., Shiva, S., Platelet mitochondrial function: from regulation of thrombosis to biomarker of disease. Biochem. Soc. Trans. 41 (2013), 118–123.
104. [104] Kramer, P.A., Ravi, S., Chacko, B., Johnson, M.S., Darley-Usmar, V.M., A review of the mitochondrial and glycolytic metabolism in human platelets and leukocytes: implications for their use as bioenergetic biomarkers. Redox Biol. 2 (2014), 206–210.
105. [105] Xu, W., Cardenes, N., Corey, C., Erzurum, S.C., Shiva, S., Platelets from asthmatic individuals show less reliance on glycolysis. PLoS One, 10, 2015, e0132007.
106. [106] Rossignol, D.A., Frye, R.E., Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol. Psychiatry 17 (2012), 290–314.
107. [107] Frye, R.E., Melnyk, S., Macfabe, D.F., Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder. Transl. Psychiatry, 3, 2013, e220.
108. [108] Oliva, C.R., Nozell, S.E., Diers, A., McClugage, S.G. 3rd, Sarkaria, J.N., Markert, J.M., Darley-Usmar, V.M., Bailey, S.M., Gillespie, G.Y., Landar, A., Griguer, C.E., Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chain. J. Biol. Chem. 285 (2010), 39759–39767.
109. [109] Kensler, T.W., Wakabayashi, N., Biswal, S., Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 47 (2007), 89–116.
110. [110] Kansanen, E., Kuosmanen, S.M., Leinonen, H., Levonen, A.L., The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biol. 1 (2013), 45–49.
111. [111] Hong, F., Sekhar, K.R., Freeman, M.L., Liebler, D.C., Specific patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activation. J. Biol. Chem. 280 (2005), 31768–31775.
112. [112] McMahon, M., Lamont, D.J., Beattie, K.A., Hayes, J.D., Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals. Proc. Natl. Acad. Sci. USA 107 (2010), 18838–18843.
113. [113] Lo, S.C., Hannink, M., PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria. Exp. Cell Res. 314 (2008), 1789–1803.
114. [114] Ricart, K.C., Bolisetty, S., Johnson, M.S., Perez, J., Agarwal, A., Murphy, M.P., Landar, A., The permissive role of mitochondria in the induction of haem oxygenase-1 in endothelial cells. Biochem. J. 419 (2009), 427–436.
115. [115] Dinkova-Kostova, A.T., Abramov, A.Y., The emerging role of Nrf2 in mitochondrial function. Free Radic. Biol. Med. 88:Part B (2015), 179–188.
116. [116] Ma, Q., Role of Nrf2 in oxidative stress and toxicity. Annu. Rev. Pharmacol. Toxicol. 53 (2013), 401–426.
117. [117] Muthusamy, V.R., Kannan, S., Sadhaasivam, K., Gounder, S.S., Davidson, C.J., Boeheme, C., Hoidal, J.R., Wang, L., Rajasekaran, N.S., Acute exercise stress activates Nrf2/ARE signaling and promotes antioxidant mechanisms in the myocardium. Free Radic. Biol. Med., 52, 2012.
118. [118] Miller, C.J., Gounder, S.S., Kannan, S., Goutam, K., Muthusamy, V.R., Firpo, M.A., Symons, J.D., Paine, R. 3rd, Hoidal, J.R., Rajasekaran, N.S., Disruption of Nrf2/ARE signaling impairs antioxidant mechanisms and promotes cell degradation pathways in aged skeletal muscle. Biochim. Biophys. Acta 1822 (2012), 1038–1050.
119. [119] Narasimhan, M., Hong, J., Atieno, N., Muthusamy, V.R., Davidson, C.J., Abu-Rmaileh, N., Richardson, R.S., Gomes, A.V., Hoidal, J.R., Rajasekaran, N.S., Nrf2 deficiency promotes apoptosis and impairs PAX7/MyoD expression in aging skeletal muscle cells. Free Radic. Biol. Med. 71 (2014), 402–414.
120. [120] Gounder, S.S., Kannan, S., Devadoss, D., Miller, C.J., Whitehead, K.J., Odelberg, S.J., Firpo, M.A., Paine, R., Hoidal, J.R., Abel, E.D., Rajasekaran, N.S., Impaired transcriptional activity of Nrf2 in age-related myocardial oxidative stress is reversible by moderate exercise training. PLoS One, 7, 2012.
121. [121] Kumar, R.R., Narasimhan, M., Shanmugam, G., Hong, J., Devarajan, A., Palaniappan, S., Zhang, J., Halade, G.V., Darley-Usmar, V.M., Hoidal, J.R., Rajasekaran, N.S., Abrogation of Nrf2 impairs antioxidant signaling and promotes atrial hypertrophy in response to high-intensity exercise stress. J. Transl. Med. 14 (2016), 1–16.
122. [122] Holmstrom, K.M., Baird, L., Zhang, Y., Hargreaves, I., Chalasani, A., Land, J.M., Stanyer, L., Yamamoto, M., Dinkova-Kostova, A.T., Abramov, A.Y., Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration. Biol. Open 2 (2013), 761–770.
123. [123] Anedda, A., Lopez-Bernardo, E., Acosta-Iborra, B., Saadeh Suleiman, M., Landazuri, M.O., Cadenas, S., The transcription factor Nrf2 promotes survival by enhancing the expression of uncoupling protein 3 under conditions of oxidative stress. Free Radic. Biol. Med. 61 (2013), 395–407.
124. [124] Piantadosi, C.A., Carraway, M.S., Babiker, A., Suliman, H.B., Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ. Res. 103 (2008), 1232–1240.
125. [125] de Duve, C., Wattiaux, R., Functions of lysosomes. Annu. Rev. Physiol. 28 (1966), 435–492.
126. [126] Zhang, J., Teaching the basics of autophagy and mitophagy to redox biologists-Mechanisms and experimental approaches. Redox Biol. 4C (2015), 242–259.
127. [127] Zhang, J., Autophagy and mitophagy in cellular damage control. Redox Biol. 1 (2013), 19–23.
128. [128] Lee, J., Giordano, S., Zhang, J., Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem. J. 441 (2012), 523–540.
129. [129] Wani, W.Y., Boyer-Guittaut, M., Dodson, M., Chatham, J., Darley-Usmar, V., Zhang, J., Regulation of autophagy by protein post-translational modification. Lab. Invest. 95 (2015), 14–25.
130. [130] Dodson, M., Redmann, M., Rajasekaran, N.S., Darley-Usmar, V., Zhang, J., KEAP1-NRF2 signalling and autophagy in protection against oxidative and reductive proteotoxicity. Biochem. J. 469 (2015), 347–355.
131. [131] Sachdeva, U.M., Thompson, C.B., Diurnal rhythms of autophagy: implications for cell biology and human disease. Autophagy 4 (2008), 581–589.
132. [132] Wei, F.Z., Cao, Z., Wang, X., Wang, H., Cai, M.Y., Li, T., Hattori, N., Wang, D., Du, Y., Song, B., Cao, L.L., Shen, C., Wang, L., Wang, H., Yang, Y., Xie, D., Wang, F., Ushijima, T., Zhao, Y., Zhu, W.G., Epigenetic regulation of autophagy by the methyltransferase EZH2 through an MTOR-dependent pathway. Autophagy 11 (2015), 2309–2322.
133. [133] Khalil, H., Tazi, M., Caution, K., Ahmed, A., Kanneganti, A., Assani, K., Kopp, B., Marsh, C., Dakhlalla, D., Amer, A.O., Aging is associated with hypermethylation of autophagy genes in macrophages. Epigenetics, 2016.
134. [134] Bernard, A., Jin, M., Gonzalez-Rodriguez, P., Fullgrabe, J., orme-Axford, E., Backues, S.K., Joseph, B., Klionsky, D.J., Rph1/KDM4 mediates nutrient-limitation signaling that leads to the transcriptional induction of autophagy. Curr. Biol. 25 (2015), 546–555.
135. [135] Fullgrabe, J., Heldring, N., Hermanson, O., Joseph, B., Cracking the survival code: autophagy-related histone modifications. Autophagy 10 (2014), 556–561.
136. [136] Fullgrabe, J., Klionsky, D.J., Joseph, B., The return of the nucleus: transcriptional and epigenetic control of autophagy. Nat. Rev. Mol. Cell Biol. 15 (2014), 65–74.
137. [137] Medina, D.L., Di, P.S., Peluso, I., Armani, A., De, S.D., Venditti, R., Montefusco, S., Scotto-Rosato, A., Prezioso, C., Forrester, A., Settembre, C., Wang, W., Gao, Q., Xu, H., Sandri, M., Rizzuto, R., De Matteis, M.A., Ballabio, A., Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nat. Cell Biol. 17 (2015), 288–299.
138. [138] Settembre, C., Zoncu, R., Medina, D.L., Vetrini, F., Erdin, S., Erdin, S., Huynh, T., Ferron, M., Karsenty, G., Vellard, M.C., Facchinetti, V., Sabatini, D.M., Ballabio, A., A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 31 (2012), 1095–1108.
139. [139] Settembre, C., Di, M.C., Polito, V.A., Garcia, A.M., Vetrini, F., Erdin, S., Erdin, S.U., Huynh, T., Medina, D., Colella, P., Sardiello, M., Rubinsztein, D.C., Ballabio, A., TFEB links autophagy to lysosomal biogenesis. Science 332 (2011), 1429–1433.
140. [140] Pyo, J.O., Yoo, S.M., Ahn, H.H., Nah, J., Hong, S.H., Kam, T.I., Jung, S., Jung, Y.K., Overexpression of Atg5 in mice activates autophagy and extends lifespan. Nat. Commun., 4, 2013, 2300.
141. [141] Bhuiyan, M.S., Pattison, J.S., Osinska, H., James, J., Gulick, J., McLendon, P.M., Hill, J.A., Sadoshima, J., Robbins, J., Enhanced autophagy ameliorates cardiac proteinopathy. J. Clin. Invest. 123 (2013), 5284–5297.
142. [142] Nakai, A., Yamaguchi, O., Takeda, T., Higuchi, Y., Hikoso, S., Taniike, M., Omiya, S., Mizote, I., Matsumura, Y., Asahi, M., Nishida, K., Hori, M., Mizushima, N., Otsu, K., The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat. Med. 13 (2007), 619–624.
143. [143] Jurkuvenaite, A., Benavides, G.A., Komarova, S., Doran, S.F., Johnson, M., Aggarwal, S., Zhang, J., Darley-Usmar, V.M., Matalon, S., Upregulation of autophagy decreases chlorine-induced mitochondrial injury and lung inflammation. Free Radic. Biol. Med. 85 (2015), 83–94.
144. [144] Rangarajan, S., Kurundkar, A., Kurundkar, D., Bernard, K., Sanders, Y.Y., Ding, Q., Antony, V.B., Zhang, J., Zmijewski, J., Thannickal, V.J., Novel mechanisms for the anti-fibrotic action of Nintedanib. Am. J. Respir. Cell Mol. Biol., 2015.
145. [145] Mitchell, T., Johnson, M.S., Ouyang, X., Chacko, B.K., Mitra, K., Lei, X., Gai, Y., Moore, D.R., Barnes, S., Zhang, J., Koizumi, A., Ramanadham, S., Darley-Usmar, V.M., Dysfunctional mitochondrial bioenergetics and oxidative stress in Akita+/Ins2-derived beta-cells. Am. J. Physiol. Endocrinol. Metab. 305 (2013), E585–E599.
146. [146] Benavides, G.A., Liang, Q., Dodson, M., Darley-Usmar, V., Zhang, J., Inhibition of autophagy and glycolysis by nitric oxide during hypoxia-reoxygenation impairs cellular bioenergetics and promotes cell death in primary neurons. Free Radic. Biol. Med. 65 (2013), 1215–1228.
147. [147] Liang, Q., Benavides, G.A., Vassilopoulos, A., Gius, D., Darley-Usmar, V., Zhang, J., Bioenergetic and autophagic control by Sirt3 in response to nutrient deprivation in mouse embryonic fibroblasts. Biochem. J. 454 (2013), 249–257.
148. [148] Dodson, M., Liang, Q., Johnson, M.S., Redmann, M., Fineberg, N., Darley-Usmar, V.M., Zhang, J., Inhibition of glycolysis attenuates 4-hydroxynonenal-dependent autophagy and exacerbates apoptosis in differentiated SH-SY5Y neuroblastoma cells. Autophagy 9 (2013), 1996–2008.
149. [149] Jaber, N., Dou, Z., Chen, J.S., Catanzaro, J., Jiang, Y.P., Ballou, L.M., Selinger, E., Ouyang, X., Lin, R.Z., Zhang, J., Zong, W.X., Class III PI3K Vps34 plays an essential role in autophagy and in heart and liver function. Proc. Natl. Acad. Sci. USA 109 (2012), 2003–2008.
150. [150] Higdon, A.N., Benavides, G.A., Chacko, B.K., Ouyang, X., Johnson, M.S., Landar, A., Zhang, J., Darley-Usmar, V.M., Hemin causes mitochondrial dysfunction in endothelial cells through promoting lipid peroxidation: the protective role of autophagy. Am. J. Physiol. Heart Circ. Physiol. 302 (2012), H1394–H1409.
151. [151] Wang, K., Zhou, L.Y., Wang, J.X., Wang, Y., Sun, T., Zhao, B., Yang, Y.J., An, T., Long, B., Li, N., Liu, C.Y., Gong, Y., Gao, J.N., Dong, Y.H., Zhang, J., Li, P.F., E2F1-dependent miR-421 regulates mitochondrial fragmentation and myocardial infarction by targeting Pink1. Nat. Commun., 6, 2015, 7619.
152. [152] Huang, C., Andres, A.M., Ratliff, E.P., Hernandez, G., Lee, P., Gottlieb, R.A., Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1. PLoS One, 6, 2011, e20975.
153. [153] Hoshino, A., Mita, Y., Okawa, Y., Ariyoshi, M., Iwai-Kanai, E., Ueyama, T., Ikeda, K., Ogata, T., Matoba, S., Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart. Nat. Commun., 4, 2013, 2308.
154. [154] Kubli, D.A., Cortez, M.Q., Moyzis, A.G., Najor, R.H., Lee, Y., Gustafsson, A.B., PINK1 Is dispensable for mitochondrial recruitment of Parkin and activation of mitophagy in cardiac myocytes. PLoS One, 10, 2015, e0130707.
155. [155] Kageyama, Y., Hoshijima, M., Seo, K., Bedja, D., Sysa-Shah, P., Andrabi, S.A., Chen, W., Hoke, A., Dawson, V.L., Dawson, T.M., Gabrielson, K., Kass, D.A., Iijima, M., Sesaki, H., Parkin-independent mitophagy requires Drp1 and maintains the integrity of mammalian heart and brain. EMBO J. 33 (2014), 2798–2813.
156. [156] Song, M., Mihara, K., Chen, Y., Scorrano, L., Dorn, G.W., Mitochondrial fission and fusion factors reciprocally orchestrate mitophagic culling in mouse hearts and cultured fibroblasts. Cell Metab. 21 (2015), 273–285.
157. [157] Ikeda, Y., Shirakabe, A., Maejima, Y., Zhai, P., Sciarretta, S., Toli, J., Nomura, M., Mihara, K., Egashira, K., Ohishi, M., Abdellatif, M., Sadoshima, J., Endogenous Drp1 mediates mitochondrial autophagy and protects the heart against energy stress. Circ. Res. 116 (2015), 264–278.
158. [158] Papanicolaou, K.N., Ngoh, G.A., Dabkowski, E.R., O'Connell, K.A., Ribeiro, R.F. Jr, Stanley, W.C., Walsh, K., Cardiomyocyte deletion of mitofusin-1 leads to mitochondrial fragmentation and improves tolerance to ROS-induced mitochondrial dysfunction and cell death. Am. J. Physiol. Heart Circ. Physiol. 302 (2012), H167–H179.
159. [159] Papanicolaou, K.N., Khairallah, R.J., Ngoh, G.A., Chikando, A., Luptak, I., O'Shea, K.M., Riley, D.D., Lugus, J.J., Colucci, W.S., Lederer, W.J., Stanley, W.C., Walsh, K., Mitofusin-2 maintains mitochondrial structure and contributes to stress-induced permeability transition in cardiac myocytes. Mol. Cell Biol. 31 (2011), 1309–1328.
160. [160] Chen, Y., Dorn, G.W., PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria. Science 340 (2013), 471–475.
161. [161] Hervouet, E., Claude-Taupin, A., Gauthier, T., Perez, V., Fraichard, A., Adami, P., Despouy, G., Monnien, F., Algros, M.P., Jouvenot, M., age-Mourroux, R., Boyer-Guittaut, M., The autophagy GABARAPL1 gene is epigenetically regulated in breast cancer models. BMC Cancer, 15, 2015, 729.
162. [162] Bai, H., Inoue, J., Kawano, T., Inazawa, J., A transcriptional variant of the LC3A gene is involved in autophagy and frequently inactivated in human cancers. Oncogene 31 (2012), 4397–4408.
163. [163] Dunwell, T., Hesson, L., Rauch, T.A., Wang, L., Clark, R.E., Dallol, A., Gentle, D., Catchpoole, D., Maher, E.R., Pfeifer, G.P., Latif, F., A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers. Mol. Cancer, 9, 2010, 44.
164. [164] Li, Z., Chen, B., Wu, Y., Jin, F., Xia, Y., Liu, X., Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors. BMC Cancer, 10, 2010, 98.
165. [165] Shukla, S., Patric, I.R., Patil, V., Shwetha, S.D., Hegde, A.S., Chandramouli, B.A., Arivazhagan, A., Santosh, V., Somasundaram, K., Methylation silencing of ULK2, an autophagy gene, is essential for astrocyte transformation and tumor growth. J. Biol. Chem. 289 (2014), 22306–22318.
166. [166] Swiderek, E., Kalas, W., Wysokinska, E., Pawlak, A., Rak, J., Strzadala, L., The interplay between epigenetic silencing, oncogenic KRas and HIF-1 regulatory pathways in control of BNIP3 expression in human colorectal cancer cells. Biochem. Biophys. Res. Commun. 441 (2013), 707–712.
167. [167] Fullgrabe, J., Lynch-Day, M.A., Heldring, N., Li, W., Struijk, R.B., Ma, Q., Hermanson, O., Rosenfeld, M.G., Klionsky, D.J., Joseph, B., The histone H4 lysine 16 acetyltransferase hMOF regulates the outcome of autophagy. Nature 500 (2013), 468–471.
168. [168] Fullgrabe, J., Klionsky, D.J., Joseph, B., Histone post-translational modifications regulate autophagy flux and outcome. Autophagy 9 (2013), 1621–1623.
169. [169] Cao, D.J., Wang, Z.V., Battiprolu, P.K., Jiang, N., Morales, C.R., Kong, Y., Rothermel, B.A., Gillette, T.G., Hill, J.A., Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc. Natl. Acad. Sci. USA 108 (2011), 4123–4128.
170. [170] Xie, M., Kong, Y., Tan, W., May, H., Battiprolu, P.K., Pedrozo, Z., Wang, Z.V., Morales, C., Luo, X., Cho, G., Jiang, N., Jessen, M.E., Warner, J.J., Lavandero, S., Gillette, T.G., Turer, A.T., Hill, J.A., Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy. Circulation 129 (2014), 1139–1151.
171. [171] Oh, M., Choi, I.K., Kwon, H.J., Inhibition of histone deacetylase1 induces autophagy. Biochem. Biophys. Res. Commun. 369 (2008), 1179–1183.
172. [172] Lee, J.Y., Koga, H., Kawaguchi, Y., Tang, W., Wong, E., Gao, Y.S., Pandey, U.B., Kaushik, S., Tresse, E., Lu, J., Taylor, J.P., Cuervo, A.M., Yao, T.P., HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy. EMBO J. 29 (2010), 969–980.
173. [173] Guo, B., Liang, Q., Li, L., Hu, Z., Wu, F., Zhang, P., Ma, Y., Zhao, B., Kovacs, A.L., Zhang, Z., Feng, D., Chen, S., Zhang, H., O-GlcNAc-modification of SNAP-29 regulates autophagosome maturation. Nat. Cell Biol. 16 (2014), 1215–1226.
174. [174] Ma, D., Panda, S., Lin, J.D., Temporal orchestration of circadian autophagy rhythm by C/EBPbeta. EMBO J. 30 (2011), 4642–4651.
175. [175] Xiong, X., Tao, R., DePinho, R.A., Dong, X.C., The autophagy-related gene 14 (Atg14) is regulated by forkhead box O transcription factors and circadian rhythms and plays a critical role in hepatic autophagy and lipid metabolism. J. Biol. Chem. 287 (2012), 39107–39114.
176. [176] Kanamori, H., Takemura, G., Maruyama, R., Goto, K., Tsujimoto, A., Ogino, A., Li, L., Kawamura, I., Takeyama, T., Kawaguchi, T., Nagashima, K., Fujiwara, T., Fujiwara, H., Seishima, M., Minatoguchi, S., Functional significance and morphological characterization of starvation-induced autophagy in the adult heart. Am. J. Pathol. 174 (2009), 1705–1714.
177. [177] Zhang, Y., Han, X., Hu, N., Huff, A.F., Gao, F., Ren, J., Akt2 knockout alleviates prolonged caloric restriction-induced change in cardiac contractile function through regulation of autophagy. J. Mol. Cell Cardiol. 71 (2014), 81–91.
178. [178] Han, X., Liu, J.X., Li, X.Z., Salvianolic acid B inhibits autophagy and protects starving cardiac myocytes. Acta Pharmacol. Sin. 32 (2011), 38–44.
179. [179] Troncoso, R., Vicencio, J.M., Parra, V., Nemchenko, A., Kawashima, Y., Del, C.A., Toro, B., Battiprolu, P.K., Aranguiz, P., Chiong, M., Yakar, S., Gillette, T.G., Hill, J.A., Abel, E.D., Leroith, D., Lavandero, S., Energy-preserving effects of IGF-1 antagonize starvation-induced cardiac autophagy. Cardiovasc. Res. 93 (2012), 320–329.
180. [180] Mitchell, T., Johnson, M.S., Ouyang, X., Chacko, B.K., Mitra, K., Lei, X., Gai, Y., Moore, D.R., Barnes, S., Zhang, J., Koizumi, A., Ramanadham, S., Darley-Usmar, V.M., Dysfunctional mitochondrial bioenergetics and oxidative stress in Akita(+/Ins2)-derived beta-cells. Am. J. Physiol. Endocrinol. Metab. 305 (2013), E585–599.
181. [181] Mitchell, T., Chacko, B., Ballinger, S.W., Bailey, S.M., Zhang, J., Darley-Usmar, V., Convergent mechanisms for dysregulation of mitochondrial quality control in metabolic disease: implications for mitochondrial therapeutics. Biochem. Soc. Trans. 41 (2013), 127–133.
182. [182] Oka, T., Hikoso, S., Yamaguchi, O., Taneike, M., Takeda, T., Tamai, T., Oyabu, J., Murakawa, T., Nakayama, H., Nishida, K., Akira, S., Yamamoto, A., Komuro, I., Otsu, K., DNA mitochondrial that escapes from autophagy causes inflammation and heart failure. Nature 485 (2012), 251–255.
183. [183] Qian, J., Scheer, F.A., Circadian system and glucose metabolism: implications for physiology and disease. Trends Endocrinol. Metab. 27 (2016), 282–293.
184. [184] Simonson, D.C., DeFronzo, R.A., Indirect calorimetry: methodological and interpretative problems. Am. J. Physiol. 258 (1990), E399–412.
185. [185] Peek, C.B., Affinati, A.H., Ramsey, K.M., Kuo, H.-Y., Yu, W., Sena, L.A., Ilkayeva, O., Marcheva, B., Kobayashi, Y., Omura, C., Levine, D.C., Bacsik, D.J., Gius, D., Newgard, C.B., Goetzman, E., Chandel, N.S., Denu, J.M., Mrksich, M., Bass, J., Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice. Science, 342, 2013.
186. [186] Durgan, D.J., Pat, B.M., Laczy, B., Bradley, J.A., Tsai, J.Y., Grenett, M.H., Ratcliffe, W.F., Brewer, R.A., Nagendran, J., Villegas-Montoya, C., Zou, C., Zou, L., Johnson, R.L. Jr, Dyck, J.R., Bray, M.S., Gamble, K.L., Chatham, J.C., Young, M.E., O-GlcNAcylation, novel post-translational modification linking myocardial metabolism and cardiomyocyte circadian clock. J. Biol. Chem. 286 (2011), 44606–44619.
187. [187] Simon, N., Papa, K., Vidal, J., Boulamery, A., Bruguerolle, B., Circadian rhythms of oxidative phosphorylation: effects of rotenone and melatonin on isolated rat brain mitochondria. Chronobiol. Int. 20 (2003), 451–461.
188. [188] Lapenna, D., De Gioia, S., Mezzetti, A., Porreca, E., Ciofani, G., Marzio, L., Capani, F., Di Ilio, C., Cuccurullo, F., Circadian variations in antioxidant defences and lipid peroxidation in the rat heart. Free Radic. Res. Commun. 17 (1992), 187–194.
189. [189] Xu, Y.Q., Zhang, D., Jin, T., Cai, D.J., Wu, Q., Lu, Y., Liu, J., Klaassen, C.D., Diurnal variation of hepatic antioxidant gene expression in mice. PLoS One, 7, 2012, e44237.
190. [190] Kakan, X., Chen, P., Zhang, J., Clock gene mPer2 functions in diurnal variation of acetaminophen induced hepatotoxicity in mice. Exp. Toxicol. Pathol. 63 (2011), 581–585.
191. [191] Zhang, D., Jin, T., Xu, Y.Q., Lu, Y.F., Wu, Q., Zhang, Y.K., Liu, J., Diurnal-and sex-related difference of metallothionein expression in mice. J. Circadian Rhythm., 10, 2012, 5.
192. [192] Garlick, P.J., Millward, D.J., James, W.P., The diurnal response of muscle and liver protein synthesis in vivo in meal-fed rats. Biochem. J. 136 (1973), 935–945.
193. [193] Lipton, J.O., Yuan, E.D., Boyle, L.M., Ebrahimi-Fakhari, D., Kwiatkowski, E., Nathan, A., Guttler, T., Davis, F., Asara, J.M., Sahin, M., The circadian protein BMAL1 regulates translation in response to S6K1-mediated phosphorylation. Cell 161 (2015), 1138–1151.
194. [194] Rau, E., Meyer, D.K., A diurnal rhythm of incorporation of L-[3H] leucine in myocardium of the rat. Recent Adv. Stud. Cardiac. Struct. Metab. 7 (1975), 105–110.
195. [195] Ma, D., Panda, S., Lin, J.D., Temporal orchestration of circadian autophagy rhythm by C/EBPbeta. EMBO J. 30 (2011), 4642–4651.
196. [196] Desvergne, A., Ugarte, N., Radjei, S., Gareil, M., Petropoulos, I., Friguet, B., Circadian modulation of proteasome activity and accumulation of oxidized protein in human embryonic kidney HEK 293 cells and primary dermal fibroblasts. Free Radic. Biol. Med. 94 (2016), 195–207.
197. [197] Pfeifer, U., Strauss, P., Autophagic vacuoles in heart muscle and liver. A comparative morphometric study including circadian variations in meal-fed rats. J. Mol. Cell. Cardiol. 13 (1981), 37–49.